Document is current
Any future updates will be listed below
-
Authors
Calhoon, Dylan https://orcid.org/0000-0002-5818-3773
Sang, Lingjie
Ji, Fubo
Bezwada, Divya https://orcid.org/0000-0002-5434-2976
Hsu, Sheng-Chieh
Cai, Feng https://orcid.org/0000-0001-5192-9520
Kim, Nathaniel
Basu, Amrita
Wu, Renfei https://orcid.org/0000-0002-8847-7254
Pimentel, Anastasia
Brooks, Bailey https://orcid.org/0000-0002-5266-9377
La, Konnor
Paulina Serrano, Ana
Cassidy, Daniel L.
Cai, Ling
Toffessi-Tcheuyap, Vanina https://orcid.org/0000-0002-6817-9241
Moussa, Maryam E.
Uritboonthai, Winnie
Hoang, Linh Truc
Kolli, Meghana
Jackson, Brooklyn
Margulis, Vitaly
Siuzdak, Gary https://orcid.org/0000-0002-4749-0014
Brugarolas, James https://orcid.org/0000-0002-8575-499X
Corbin, Ian
Pratt, Derek A. https://orcid.org/0000-0002-7305-745X
Weiss, Ryan J. https://orcid.org/0000-0002-4563-6075
DeBerardinis, Ralph J. https://orcid.org/0000-0002-2705-7432
Birsoy, Kıvanç https://orcid.org/0000-0002-7579-9895
Garcia-Bermudez, Javier https://orcid.org/0000-0001-5274-7040
- License Information
-
More Information
Article History
Received: 22 May 2024
Accepted: 15 May 2025
First Online: 11 June 2025
Competing interests
: K.B. is scientific advisor to Nanocare Pharmaceuticals and Atavistik Bio. R.J.D. is a founder at Atavistik Bio and serves on the scientific advisory boards of Atavistik Bio, Agios Pharmaceuticals, Faeth Therapeutics, General Metabolics and Vida Ventures. The other authors declare no competing interests.
